Jf. Schved et al., A PROSPECTIVE EPIDEMIOLOGIC-STUDY ON THE OCCURRENCE OF ANTIPHOSPHOLIPID ANTIBODY - THE MONTPELLIER ANTIPHOSPHOLIPID (MAP) STUDY, Haemostasis, 24(3), 1994, pp. 175-182
The objective of this study was to determine the prevalence and clinic
al significance of elevated antiphospholipid antibodies (APA) in a lar
ge series of patients admitted to a departament of Internal Medicine.
At the end of entry phase, 1014 patients were tested (488 males-526 fe
males, mean age: 66,7 years, range 18-97). Seventy-two (7.1 %) patient
s were found APA positive at least once: 44 males and 28 females, mean
age 69 years, range 23 to 94. Twenty fulfilled the criteria of Primar
y Antiphospholipid Antibody Syndrome: 10 patients were referred for de
ep vein thrombosis, 3 had history of deep vein thrombosis, 1 had both
arterial thrombosis and a history of venous thrombosis; 2 had thromboc
ytopenia; 3 had stroke, 1 had a history of s troke. One patient had SL
E according to ARA classification. The most frequent associated diseas
e was cancer: 14 patients, 9 had evolutive malignant disease, 5 were i
n clinical remission of neoplasia. Other clinical conditions included
chronic and/or acute alcoholic intoxication (n=8), severe atherosclero
sis (n=4), leg ulcer (n=4). Insufficient data are available about the
evolution, but 7 patients died in the year following diagnosis. Eight
patients had fluctuations in APA detection: 2 initially APA positive b
ecame negative, 5 initially negative became positive and I patient was
alternatively positive, negative and positive without steroid treatme
nt. Thus, as expected, APA occur in a variety of clinical disorders. T
he association with cancer or alcoholic intoxication deserves further
investigations.